Fairvalue-Calculator Fairvalue-Calculator
EN DE

Integral Diagnostics Limited (IDX) Fair Value & Analysis

Healthcare · AU · Market cap A$772M

PriceA$1.97
Fair ValueA$0.5800
Upside-70.5%
Quality95/100
Evidence: High Range A$0.5400 – A$1.06

Analysis

Integral Diagnostics Limited (IDX) currently trades at A$1.97, while our model-based Fair Value estimate is A$0.5800 — implying the stock looks roughly 70.5% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as x-ray and EOS. Integral Diagnostics Limited was founded in 1967 and is headquartered in Melbourne, Australia.

Open the full interactive analysis →

Similar stocks

Thermo Fisher Scientific Inc (TMO) -30% Danaher Corporation (DHR) -37% WuXi AppTec Co (WUXAY) +35% IDEXX Laboratories, Inc (IDXX) -53% Lonza Group (LZAGY) -74% Agilent Technologies, Inc (A) -50%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.